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Abstract 
Aim: To identify and classify characteristics associated with smoking cessation during pregnancy from a 
systematic review of the research literature and meta-analysis. 
Methods: Electronic searches of the bibliographic databases of PubMed, EMBASE, PsycINFO, Elsevier, 
Scopus and ISI Web of Science were conducted to April 2017. All studies reporting factors associated 
with smoking cessation or continuing smoking during pregnancy were included and systematically 
reviewed, irrespective of study design. The Newcastle Ottawa Quality Assessment Scale was used to 
assess the study quality. The DerSimonian and Laird random effects model was used to conduct meta-
analyses, and where effect estimates were reported for factors included in at least three studies. 
Results: Fifty-four studies including 505,584 women globally who smoked before pregnancy, 15 clinical 
trials and 40 observational studies, were included in the review and 36 (65.5%) were considered to be of 
high quality. This review identified 11 socio-demographic, seven socially related, 19 smoking behaviour 
related, five pregnancy related, six health related and six psychological factors that were significantly 
associated with smoking cessation during pregnancy. The most frequently observed significant factors 
associated with cessation were: higher level of education, pooled OR (95% CI): 2.16 (1.80-2.84), higher 
socio-economic status: 1.97 (1.20-3.24), overseas maternal birth: 2.00 (1.40-2.84), Medicaid coverage or 
private insurance: 1.54 (1.29-1.85), living with partner or married: 1.49 (1.38-1.61), partner/other 
members of the household do not smoke: 0.42 (0.35-0.50), lower heaviness of smoking index score: 0.45 
(0.27-0.77, lower baseline cotinine level: 0.78 (0.64-0.94), low exposure to second hand smoking: 0.45 
(0.20-1.02), did not drink alcohol  before and/or during pregnancy: 2.03 (1.47-2.80), primiparity: 1.85 
(1.68-2.05), planned breastfeeding:1.99 (1.94-2.05), perceived adequate pre-natal care: 1.74 (1.38-2.19), 
no depression: 2.65 (1.62-4.30), and low stress during pregnancy: 0.58 (0.44-0.77). 
Conclusion: Many characteristics are associated with smoking cessation during pregnancy, falling into 
every category of socio-demographics, relationship and social factors, smoking behaviour, pregnancy 
related factors, health status and psychological factors.  
Key words: Smoking, cessation, pregnancy, predictors, determinants, systematic review, meta-analysis, 
clinical trials, observational studies, interventions. 
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INTRODUCTION  
Smoking in pregnancy is a serious public health problem and one of the main preventable causes of 
pregnancy-related morbidity and death. Smoking is associated with adverse pregnancy and birth outcomes, 
including miscarriage, stillbirth, prematurity, low birth weight, intrauterine growth restriction, congenital 
abnormalities, and neonatal or sudden infant death [1-5]. Smoking also presents immediate risks for the 
mother, including placental abruption [6], as well as the longer-term risks reported for smokers in general 
[7]. 
In high income countries, the prevalence of smoking in pregnancy is estimated to be between 10% and 
26% and is decreasing rapidly in many of these countries [8-12]; whereas, in low and middle-income 
countries the prevalence is between 15% and 37% and is not declining in some of these countries [13-16]. 
Smoking cessation during pregnancy improves maternal and birth outcomes [17], yet only about 25% of 
pregnant smokers stop for at least part of their pregnancy and half to two thirds of them return to smoking 
after giving birth [18]. Regular sessions of face-to-face behavioural support is the main intervention 
demonstrated to be effective as an aid to smoking cessation during pregnancy [17], which can be enhanced 
when supplemented with financial incentives [19]. 
To promote successful maternal smoking cessation during pregnancy, clinicians and researchers need to 
identify factors that facilitate or inhibit the quitting process. These factors can then be targeted directly, by 
smoking cessation interventions, or indirectly by promoting cessation interventions to subgroups of 
women who are less likely to succeed at quitting [20, 21]. For example, this might include women from 
socially deprived groups, those with higher levels of cigarette dependence, and women living with a 
partner who smokes [22, 23]. 
The most recent systematic review of predictors of smoking cessation during pregnancy was conducted in 
2010 [23] and it considered 19 studies which identified socio-demographic/economic, relationship, 
psychological, pregnancy and health related factors as predictors. However, this review was limited to 
studies in high-income countries published between 1997 and 2008, and excluded intervention studies. 
There have been a large number of studies published since this previous review was undertaken. 
Furthermore, additional factors have since been examined as predictors of cessation during pregnancy, 
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such as smoking dependence variables (e.g., Fagerström Test for Cigarette Dependence and urges to 
smoke), as well as variables related to pregnancy, such as adequate pre-natal care, planned breast feeding 
and planned pregnancy. Moreover, a meta-analysis has not been previously conducted on this topic.  
This comprehensive systematic review was conducted to examine a wide range of factors that may be 
associated with smoking cessation during pregnancy. Further aims include conducting meta-analysis for 
the frequently reported factors and classifying factors associated with cessation into sub-categories, 
including socio-demographic/economic, relationship and social activity, smoking, psychological, 
pregnancy and health related factors, to help clinicians to target interventions towards different sub-groups 
of the pregnant population or to inform the development of interventions. 
METHODS 
This review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) statement [24].  
Strategies for searching the literature  
We developed a search strategy and conducted the literature searches in the bibliographic databases of 
PubMed, EMBASE, PsycINFO, Elsevier, Scopus and ISI Web of Science. The search was designed to 
capture all studies reporting factors (predictors) associated with smoking cessation during pregnancy. The 
search terms were: [“predictors” or “factors” or “determinants” or “characteristics” or “component”] and 
[“psychological” or “demographic”] and [“pregnancy or pregnant”] and [“smoking cessation” or “smoking 
or smoker”]. Based on the combinations of these terms, several searches were conducted in the above-
mentioned databases. We examined all the studies included in the previous review [23]. There was no 
restriction on language and the search was completed in April 2017.  
Inclusion and exclusion criteria 
Smoking cessation or continued smoking during pregnancy were considered as the analyses outcomes. 
This included bio-chemically validated and non-validated self-reported smoking cessation, and covered 
both planned and spontaneous quit attempts [25], at any time during pregnancy. Studies were included 
which statistically examined the association of smoking cessation or continuing smoking during pregnancy 
with other factors, irrespective of study design. If a study was designed to evaluate an intervention, such as 
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Nicotine Replacement Therapy, we did not report the intervention as a predictor. We excluded those 
studies which include non-smoking women before pregnancy, women who had stopped smoking prior to 
pregnancy, studies reporting predictors of postpartum smoking cessation, and qualitative studies (i.e., 
narrative and case reports). Studies identified by search strategies were screened for eligibility; initially on 
the basis of title and abstract, and then reading the full text of the remaining studies. One reviewer (M.R.) 
screened all studies for inclusion with one-third also screened independently by another reviewer (M.U.), 
with 100% agreement. A hand-search of the reference lists of included studies was also conducted. 
Corresponding authors were contacted for additional information where necessary. 
Data extraction 
The following data was extracted from each study by M.R. and was verified by M.U: first author name, 
year and location of publication, study aim and design, participant characteristics, including age and 
smoking behaviours, sample size and smoking cessation rate, main outcome measure, biochemical 
validation, whether all smokers made a quit attempt, variables examined as predictors, statistical methods 
used for the analysis, and statistically significant predictors reported, and effect estimates for the 
association (e.g., ORs and 95% confidence intervals CI). 
To aid the description, those factors found to be significantly associated with smoking cessation were 
categorised by grouping thematically similar factors across the included papers. The categories were 
decided through reference to categories used in a review by Schneider and colleagues [23] and through 
discussion involving all authors. Potential predictors were grouped into the following domains: socio-
demographic/economic, relationship, smoking/substance misuse, psychological, pregnancy and health 
related factors. They were also categorised according to the nature of association with smoking cessation 
(i.e., increasing or decreasing odds ratio). 
Meta-analyses 
A large number of factors significantly associated with smoking cessation during pregnancy are identified 
in this review. However, to pool the effect estimates in a way that will yield valuable information about 
the direction and size of effects and to quantify heterogeneity among the included studies, we conducted 
meta-analyses for those factors whose effect estimates were available from at least three studies. We 
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extracted the effect estimates (95% confidence intervals), reported as odds ratios (OR: majority), relative 
risk ratios (RR: one study [69]) or prevalence ratios (PR: one study [21]). If an effect estimate was not 
reported, an unadjusted OR and 95% confidence interval (95% CI) was estimated from the available data. 
To ensure consistency of the effect estimates for meta-analysis, for some of the studies, the effect 
estimates were transformed such that the appropriate reference category was used with smoking cessation 
as the outcome. For example, for the meta-analysis of older maternal age as a categorical predictor, we 
extracted effect estimate (ORs) for the oldest versus the youngest age category. If a study reported an 
effect estimate for the youngest age category versus oldest age category, we transformed the OR (95% CI) 
by taking the multiplicative inverse. Similarly, if a study reported OR (95% CI) for continuing smoking 
versus quitting, we used the multiplicative inverse to compute OR (95% CI) for quitting versus continuing 
smoking. Assuming heterogeneity of effects, we used DerSimonian and Laird [26] random effects model 
for the meta-analyses to compute pooled effect estimates and a heterogeneity index I2. The meta-analyses 
results were reported as pooled OR (95% CI), along with I2 and p-values. 
Quality assessment 
The included studies were randomised controlled trials (RCTs) and observational (cohort and cross-
sectional). To assess study quality, we used the Newcastle Ottawa Quality Assessment Scale (NOQAS) 
developed for cohort studies [27] and the modified version of the (NOQAS) developed for cross-sectional 
studies [28]. In the modified version of the scale, criteria for the “ascertainment of exposure” was not 
applicable in this review, therefore we used the original criteria as given in the NOQAS for cohort studies. 
For predictors’ analyses, the overall sample of the RCT had been used as for observational cohorts; 
therefore, we assessed the quality of RCTs using the cohort studies scale of NOQAS. The maximum 
possible score of NOQAS was 9 and we used a standard cut-off of 7 to identify studies with high quality 
methodology. Studies were included in the review irrespective of their rating of quality. Quality 
assessment was conducted by two independent reviewers (M.R and S.L), who discussed any discrepancies 
until agreement was met.  
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RESULTS  
The initial search returned more than ten thousand hits; on the basis of the title or abstracts this was 
reduced to 91 studies and, after reading the papers, 55 studies (40 observational and 15 RCTs) were 
included in this review (see Figure 1). The characteristics of these studies, including a summary of the 
results of the predictors’ analysis, are presented in supplementary table S1. 
Characteristics of the included studies 
Design  
Of the 40 observational studies, 19 were cross-sectional [21, 51-53, 55-57, 59, 61-63, 66, 73, 75, 77, 79- 
81, 82] and 21 were cohort studies [44-50, 54, 58, 60, 64, 65, 67-72, 74, 76, 78]. Fifteen studies used 
secondary data from RCTs [29-43].  
Study location 
Of the observational studies, 12 were from North America (USA=11, Canada=1), 19 were European 
(multinational=2, UK=2, France=1, Denmark=1, Italy=1, Netherland=2, Norway=4, Serbia=1 and 
Spain=5), five were from Asia (Japan=2, Lebanon=1, Taiwan=1 and Israel=1) and four were from 
Australasia (Australian=3, New Zealand=1). Twelve of the 15 RCTs were from the USA, two were from 
the UK and one from France. 
Participants 
Among the 55 included studies, the combined total number of women who smoked before pregnancy was 
505,584. All the studies recruited participants who were at least 16 years of age and the mean age of the 
women ranged from 16 to 50 years. Of the seventeen studies (31.5%) that reported quit attempts, all or 
most of the participants made a quit attempt in fifteen studies [21, 29, 30, 33, 34, 35, 36, 37, 39, 41, 42, 43, 
49, 75, 81], whilst two other studies reported quit attempts for only 17% [32] and 30% [80] of the 
participants. 
Outcome of biochemical validation 
Sixteen studies, three observational [44, 52, 71] and thirteen RCTs [29, 31-37, 39-43], reported predictors 
of biochemically validated smoking abstinence in pregnancy, using salivary or urine cotinine and/or 
expired carbon monoxide (CO) or urine thiocyanate assays. Three of the observational studies [52, 62, 63] 
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and two of the RCTs [40, 43] reported predictors of spontaneous quitting during pregnancy without 
biochemical validation.  
Sample size 
Thirty of the observational studies and ten of the RCTs had large sample sizes (>300) to detect small-
moderate effect sizes. These ranged from N=303 to N=231,143 for observational studies and N=316 to 
N=957 for the RCTs. Ten of the observational studies and five of the RCTs had small sample sizes (range 
N=35 to N=226) [44, 48, 52, 53, 55, 56, 58, 66, 70, 75] and (range N=81 to N=289) [30, 33, 35, 36, 40], 
respectively, which were likely to detect only large effect sizes.  Of the 13 trials with biochemical 
validation, nine were sufficiently powered (range N= 316 to N=957) to detect small-moderate effect sizes 
for predictors of abstinence [29, 31, 32, 34, 37, 39, 41-43]. 
Quality Assessment 
The median Newcastle-Ottawa Quality Assessment Scale [27, 28] score was 7.0 (range 5–9) for cohort 
studies (including RCTs) and 6.6 (range 4–8) for cross-sectional studies (see supplementary tables S2 and 
S3). Of the 55 included studies, 36 (65.5%) were considered to be of high quality (cohort: 29, 31, 32, 34, 
36. 37, 39, 41, 42, 45-47, 49, 50, 54, 60, 64, 65, 67, 69, 72, 74, 76, 78; cross-sectional: 21, 51, 57, 61-63, 
73, 77, 79-82). Nineteen (34.5%) were deemed to be of low quality. The main reasons for lower quality 
were non-representativeness of the underlying population, non-validation of self-reported outcome, low 
sample size or limited adjustment for potential confounders in the statistical analysis. 
Smoking cessation rates 
Smoking cessation rates reported in the 40 observational studies ranged from 4.0% to 76.2% and from 
4.3% to 66.0% in the RCTs. 
Analyses techniques  
For the majority of the included studies, statistical analyses to assess the associations were performed 
using simple and multiple logistic regression, or mixed effect logistic models, with smoking status during 
pregnancy as the dependent variable and other factors as independent variables. However, it is worth 
mentioning that the outcome definition is very heterogeneous (see column 4 in supplementary Table S1). 
Moreover, four of the RCTs [29, 30, 33, 34] and five of the observational studies [53, 56, 59, 66, 75] did 
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not report adjusting for important potential confounders such as age, parity, cigarette dependence, or used 
analyses other than logistic or mixed effect logistic regression. In addition, seven of the RCTs did not 
report adjusting for the effect of intervention [30, 32-34, 38, 40, 43]. 
Predictors of smoking cessation  
Fifty-four factors significantly associated with smoking cessation are presented in Table 1 and the forest 
plots are presented in supplementary Figure S1. When we repeated the synthesis for studies where most or 
all participants made a quit attempt, similar factors were identified, and in particular there were 
significantly reported factors of socio-demographics, relationship and social activity, smoking behaviour, 
pregnancy, health status, and psychological factors. No meaningful differences of predictors were 
identified in studies that used biochemical validation compared with those that did not.  
In the following sections, the statistically significant factors are classified into sub-groups with a 
narrative description of the findings.  
Socio-demographic factors 
The socio-demographic factors that were significantly associated with higher likelihood of smoking 
cessation during pregnancy include older maternal age [21,37, 54, 64, 68, 67, 74], ethnicity - non-white 
[50] non-Puerto Rican Hispanic [61, 69] and non-aboriginal [74, 67], overseas maternal birth [61, 67, 74, 
79], higher level of maternal education [21, 31, 32, 34, 40, 41, 43, 47, 49, 51, 54, 55, 60, 63, 64, 68, 69, 
71, 76, 77, 80, 82] or paternal education [49], higher income level [21, 48, 67, 82], currently employed 
women [70], and private medicaid insurance [38, 40, 47, 51, 74]. In contrast, other studies found older age 
[38, 47, 50, 51, 66, 69, 76, 82] to be associated with a lower likelihood of smoking cessation during 
pregnancy. 
Relationship and social activity factors 
Women were more likely to quit during pregnancy if they were married or living with a partner [43, 51, 
54, 64, 65, 69, 71, 77], were housewives [77], and had support from partner and/or others [46]. Women 
were less likely to quit if they had a partner or household member who smoked [21, 38, 44, 46, 59, 62, 70, 
71, 72, 73,75, 76, 78, 79, 82] or had exposure to second-hand/environmental smoking [32, 42, 44, 63, 71], 
had a poor maternal childhood, defined as brought up without father being around or father’s employment 
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status was unknown to her, or had a poor current circumstances, which is defined as becoming a mother at 
a younger age and currently not cohabiting [60].  
Smoking or substance use related factors 
Smoking related variables that significantly predicted lower odds of cessation in pregnancy included: 
higher cigarette consumption before pregnancy as a categorical variable [32, 34, 36, 39, 40, 44, 45, 47,48, 
51, 54, 55, 56, 58, 61, 62, 63, 65, 66, 68, 69, 72, 73, 80, 82] and as a continuous variable [37, 43, 76], 
higher baseline cotinine level [31, 41, 42] or expired CO level [39], higher Fagerstrom Test of Cigarette 
Dependence score [39], higher scores for Heaviness of Smoking Index [36, 39, 59] or non-Heaviness of 
Smoking Index [39], higher ratings of urges to smoke [39, 59] or withdrawal symptoms [59], if women 
reported shorter time to smoke their first cigarette on awaking [37,36, 38], younger age at the onset of 
smoking [43, 78] and consumption of more coffee during pregnancy [72]. Women were more likely to quit 
if they: had smoked for a shorter duration [42, 48], did not smoke their first cigarette within 30 minutes of 
awaking [37,36, 38], maintaining complete abstinence during the initial two weeks of quit attempt in early 
pregnancy [35], had a pre-pregnancy/prior quit attempt [34, 36], interaction of age and duration of 
smoking (i.e., younger (18-24 years) women who smoked for shorter duration (< 10 years)) [81], used 
marijuana before pregnancy [61], did not drink alcohol before and/or during pregnancy [47, 49, 58, 82], 
and interaction of delayed discounting and smoking rate at baseline (i.e., those who had delayed 
discounting of spontaneous quit and lower smoking rate at baseline) [43].  
Pregnancy related factors 
Pregnancy related factors found to be significantly associated with a higher rate of smoking cessation 
during pregnancy were: primiparity (i.e., women with no previous pregnancy) [33, 44, 45, 47, 48, 49, 51, 
52, 60, 61, 63, 65, 67, 70, 71, 73, 74, 75, 77, 78, 79, 82], perceiving to have received adequate prenatal 
care [48, 67, 69, 73, 74, 80], having planned breast feeding [50,58, 69, 82], having had a prior pre-term 
birth [69], and having had planned pregnancy [77, 79].  
Health related factors 
The health related factors that were significantly associated with higher rates of smoking cessation were:  
severe nausea [44, 70], family history of diabetes [61], use of folic acid [77], and had a known higher risk 
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of foetal harm [59]. Women were less likely to quit who had short sleep duration [63], and were holders of 
a community services card (a healthcare subsidy for low-income earners) [70].  
Psychological factors 
Finally, the psychological predictors that were reported to be significantly associated with lower likelihood 
of smoking cessation were: higher levels of anxiety [57] or stress [34, 43, 57, 59, 61], and domestic 
violence [57]. Women were more likely to quit during pregnancy if they had no depression [30, 31, 40, 
52], had higher self-efficacy for quitting [32, 37, 42, 53] or readiness to quit [52], or held a stronger belief 
that smoking will harm their baby [43]. 
Meta-analyses results 
For eighteen of the factors, which have been reported by at least three studies and have effect estimates 
available, meta-analysis were conducted. For all except age, the pooled effect estimates were significant 
statistically. The number of studies included in the meta-analysis, direction and sizes of effects (ORs , 95% 
CI) were as follow: older maternal age (categorical, 11 studies: 0.96 (0.72-1.28) and (continuous, 4: 0.98 
(0.95-1.02)), overseas maternal birth (4: 2.00 (1.40-2.84)), higher level of maternal education (20: 2.16 
(1.80-2.59)), higher income level (3: 1.97 (1.20-3.24)), private medicaid insurance (5: 1.54 (1.28-1.85), 
living with partner/married (7: 1.49 (1.38-1.61)), partner or household member smokes (14: 0.42 (0.35-
0.50)), higher exposure to second-hand smoking (3: 0.45 (0.20-1.02)), higher level of  Heaviness of 
Smoking Index (3: 0.45 (0.27-0.77)), higher pre-pregnancy cigarette consumption (categorical, 20: 0.28 
(0.22-0.35) and continuous, 3: 0.57 (0.38-0.85)), higher baseline cotinine level (3: 0.78 (0.64-0.94)), pre-
pregnancy lower time to first cigarette on waking (3: 0.37 (0.23-0.59)), did not drink alcohol before and/or 
during pregnancy (4: 2.03 (1.47-2.80)), primiparity (18: 1.85 (1.68-2.05)), women who were perceived to 
have adequate prenatal care (5: 1.74 (1.38-2.19)), planned  breastfeeding (4: 1.99 (1.94-2.05)),  women not 
having depression (3: 2.65 (1.62-4.30)) or  having stresses (3: 0.58 (0.44-0.77)) during pregnancy, (Table 
1 and Figure 1S). 
Sources of heterogeneity 
In the meta-analyses, the heterogeneity index I2 ranged from 0% to 98.6%; it was very high (≥75%) for ten 
of the factors (e.g., I2 for categorical age is 96.0% and for continuous age is 88.9%, p<0.001), and 
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moderate (50%≤ I2 <75%) for four factors [96]. For no alcohol use before and/or during pregnancy, 
planned breastfeeding, not having depression or having stress during pregnancy, there was no 
heterogeneity (I2=0%); however, meta-analyses for the latter two factors exclude effect estimates from 
some of the studies (Table 1 and Figure S1). Heterogeneity among the studies may be due to the design 
(i.e., RCT, observational cohort and cross-sectional), the use of different analytical techniques, outcome 
definition, differences in how the predictors (exposure) were measured or analysed in different studies, 
rates of smoking cessation, time of outcome assessment during pregnancy, study follow-up period and 
gestational age at baseline. 
 
DISCUSSION 
We extracted a wide range of factors that are associated with smoking cessation during pregnancy from 55 
studies including over a half a million women who smoked before pregnancy. The observed significant 
predictors of cessation were: higher socio-economic status (i.e., higher level of maternal education, higher 
income level or private medicaid insurance), overseas maternal birth, living with partner or married, lower 
exposure to passive smoking (i.e., partner/other members of the household do not smoke or low exposure 
to second hand smoking), low cigarette dependence(i.e., pre-pregnancy cigarettes consumption, lower time 
to first cigarette on waking, low baseline cotinine or heaviness of smoking index), low exposure to second 
hand smoking, not drinking alcohol before and/or during pregnancy, primiparity, perceived adequate pre-
natal care, planned breast feeding, good mental health during pregnancy(i.e., no depression or stress), and 
higher levels of self-efficacy for quitting. 
The findings have implications for the design of smoking cessation interventions and for public health 
policy. First, our findings, especially regarding socio-demographic and pregnancy related factors, can help 
identify and prioritise women who are at increased risk of failing to quit or relapsing. This might include 
women who are of lower education, lower socio-economic status, multiparous and single. Secondly, some 
characteristics are likely to have a more direct impact on smoking cessation and might be most appropriate 
for including as intervention components. For example, high cigarette dependence, having a partner who 
smokes and low levels of self-efficacy for quitting, can be targeted, respectively, by pharmaceutical 
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interventions [84], behavioural support that attempts to boost self-efficacy [90], and couple-focused 
interventions to help partners to quit [85-87] where probably the most work is needed. 
There are also characteristics that are likely to have a less direct impact on cessation, but that can still 
inform interventions. For example, more work is needed on depression focussed interventions [83] and 
interventions providing encouragement and incentives for breastfeeding [88, 89]. 
There are some similarities and some difference between the factors associated with smoking cessation 
observed in this review, and those reported for the general population of smokers. Factors which are also 
associated with cessation in the general population include higher socio-economic status, low cigarette 
dependence, and higher levels of self-efficacy [91]. Whereas factors reported here, but not found for 
smokers in general, include marital status, no use of alcohol, good mental health, and low exposure to 
second-hand smoke. Thus, while targeting and developing interventions for pregnant smokers there are 
several additional factors, including pregnancy related factors, that needed to be considered. 
Compared with a previous review of the predictors of smoking cessation during pregnancy [23], we 
identified a broader set of predictors and included a larger number of studies based on up to date searches 
using robust review procedures. Also, we included studies from high-income countries globally and sought 
to include studies from low-middle income countries (LMICs), but identified only two studies from 
LMICs. Furthermore, a major limitation in previous reviews is the lack of included studies using 
biochemical confirmation of self-reported smoking cessation and without such validation it is unclear what 
proportion of participants have falsified their smoking status. In our review, we included 15 studies that 
used data from RCTs, 13 of which used biochemical validation, and three of the observational studies also 
used biochemical validation. A further strength of our review compared with previous reviews is that we 
included a thorough study quality assessment using established scales [27, 28]. 
A limitation with the literature reviewed is that the majority of studies are observational, used varied 
definitions for smoking cessation and had varying sample sizes. Some of the studies did not specifically 
seek to identify the predictors of smoking cessation but reported them while evaluating the effect of an 
intervention. A further limitation with the findings is that the majority of the studies either did not report 
whether all participants made a quit attempt or reported that only some made an attempt. These studies 
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combined those who actively attempted to quit with those who did not. This may have distorted the 
findings, as a review of predictors of smoking behaviour in the general population of smokers identified 
that while many factors predict making a quit attempt, very few factors predict abstinence when only 
including those who actually made a quit attempt [91]. A further limitation was the quality of the studies 
included. On the basis of our quality assessment, 19 (35%) of the studies were considered to be of low 
quality due to low representativeness, low statistical power, design, analyses and no adequate follow ups; 
however, we have highlighted the findings separately for the high quality studies. It is worth 
acknowledging that NOQAS itself has known limitations, such as it often does not inform the evidence 
synthesis process, particularly for systematic reviews of non-randomised studies, including sensitivity 
analysis, narrative assessment and restricting the synthesis to studies at a lower risk of bias, which have 
been discussed elsewhere in some detail [93, 94, 95]. However, NOQAS is a widely used tool for quality 
assessment in systematic reviews and we assessed the quality using NOQAS only and did not exclude any 
studies based on it. 
This is the first study to conduct meta-analysis for a range of predictors of cessation in pregnancy. 
Meta-analysis was conducted only for factors with effect estimates reported by at least three studies, and 
we could not include all estimates as the appropriate data was not always available. These analyses yielded 
important information about the strength of association and the amount of heterogeneity between studies. 
For example, when the effect estimates for maternal older age were pooled, no significant effect was 
observed statistically, and there was high heterogeneity in effect estimates among the studies. There was a 
high degree of heterogeneity for many of the factors investigated, and we used a random effects model to 
allow for between study heterogeneity. We have described potential sources of heterogeneity including 
study design, study population, measuring and assessing factors, outcome measure, and timing of outcome 
measure during pregnancy and when there are sufficient studies, this could be explored in the future 
through meta-regression. The pooled analysis was weighted by the inverse of variance but we did not use 
meta-regression, to further explore heterogeneity. As such, the aim of this review was to report the 
ﬁndings narratively and for the majority of the factors meta-analysis was not conducted due to being 
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reported by less than three studies, hence, the meta-analyses results must be viewed and interpreted 
cautiously. 
This review identified only two studies from LMICs (Serbia and the Lebanon); interestingly, the factors 
associated with smoking cessation in these countries were similar to those identified in women from the 
high-income nations (i.e., higher socio-economic status, other members of the household do not smoke, 
low cigarette dependence, perceived adequate pre-natal care). Further work is needed to explore whether 
the predictors are the same for LMICs versus high income nations, particularly in relation to factors which 
are likely to be distinct in poorer nations, such as provision of health services and education. This issue is 
particularly important due to concerns that smoking among pregnant women in LMICs is declining more 
slowly compared with high income countries. 
Further research is also needed focusing on predictors for which there were not consistent findings 
(e.g., maternal age) or where there were few high quality studies showing significant effects (e.g., 
ethnicity, nicotine dependence, urges to smoke, and psychological variables such as readiness to quit). It is 
not clear why the findings were inconsistent for maternal age, although this is likely to be partly due to 
variation in how the age variable was defined (e.g., categorical versus continuous) in the different studies. 
However, our thorough meta-analysis for age concluded that it is not a significant predictor. Research is 
also required to investigate predictors of quit attempts, which are likely to be distinct from the predictors 
of success of those attempts [91]. Finally, as has been done with predictors of post-partum return to 
smoking [92], studies are needed to explore direct and indirect pathways linking predictors with smoking 
cessation during pregnancy, thereby further focussing the priorities for intervention development. 
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Figure 1: Flow diagram of eligible studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Factors significantly associated with smoking cessation during pregnancy 
15 Studies used data 
from RCTs 
 
40 Observational 
55 papers met the inclusion criteria and were 
included.  
Total number of pregnant women=505,584 
  
From the initial search 10,753 titles or 
abstracts were identified and screened for 
retrieval 
21 Cohort studies 
91 full-text articles assessed 
19 Cross-sectional 
studies 
36 papers were excluded as being 
not relevant:   
10 include non-smoking women 
or women who had stopped before 
pregnancy 
3 reported predictors of 
postpartum cessation 
4 did not report specific 
predictors 
8 were qualitative research  
5 reported intervention only 
1 studied predictors of alcohol 
and tobacco use combined 
2 combined data on pregnant and 
non-pregnant smokers  
3 were previous reviews 
  
   
10,662 papers were excluded as 
being not relevant or duplicates 
 
    Page 27 of 31 
 
Factors associated with 
cessation  
Study no: extracted effect estimatesa and pooledcodds ratios  
  ORs/RRs (95% CI)b MA: Pooled 
ORc (95% CI), 
(I2, p) 
Socio-demographic and 
economic factors 
  
Older age 38: 0.98 (0.97-0.99),    [21: 1.55 (1.17-2.05),   
54: 2.09 (1.00-4.30),    64: 1.42 (1.28-1.57),    
68: 2.10 (1.10-4.20),    69: 0.75 (0.70-0.79),    
74: 1.89 (1.56-2.27),    47: 0.30 (0.16-0.56),    
50: 0.92 (0.88-0.97),    51: 0.71 (0.62-0.83),    
66: 0.22 (0.07-0.76),    67: 1.19 (1.01-1.41),    
76: 0.96 (0.94-0.98),    82: 0.31 (0.19-0.53)]*, 
[37: 1.11 (1.04-1.17)]*ϯ 
d:  
0.96 (0.72-1.28), 
(96.0%, <0.001) 
e: 
0.98 (0.95-1.02), 
(88.9%, <0.001) 
Ethnicity-non-White 
women 
[50: 2.70 (1.31-5.58)]*  
Ethnicity-non-Puerto Rican 
Hispanic 
[61: 1.54 (1.11-1.88),    69: 2.12 (1.95-2.31)]*  
Ethnicity (Australian-
aboriginal) 
[74: 0.60 (0.50-0.70),    67: 0.54 (0.43-0.66]*  
Overseas maternal birth 
(immigrant) 
[61: 1.73 (1.02-2.94),    67: 2.71 (2.15-3.43),   
79:  2.17 (1.03-4.54),    74: 1.60 (1.44-1.78)]* 
2.00 (1.40-2.84), 
(81.9%, 0.001) 
Non-Urban resident  [74: 0.70 (0.60-0.90)]*  
Higher level of maternal 
education  
[21: 2.69 (1.60-4.53),    34: 4.40 (1.5-12.8),    
41: 1.82 (1.24-2.67),     49: 1.24 (1.07-1.43)]*ϯ 
 
31: 2.43 (1.30-4.54),      40: 1.37 (1.05-1.75),     
43: 4.62 (1.70-12.54),    47: 1.90 (1.40-2.70),       
51: 1.74 (1.44-2.10),      54: 2.73 (1.90-4.00),   
55: 2.50 (1.20-5.50),      60: 1.72 (1.04-2.86),          
63: 1.83 (1.28-2.62),      64: 1.31 (1.23-1.38), 
68: 2.60 (1.30-5.20),      69: 2.29 (2.18-2.40), 
71: 3.20 (1.60-6.50),      76: 1.91 (1.55-2.35),     
77: 3.64 (2.58-5.14),      80: 2.03 (0.99-4.15), 
82: 3.33 (1.67-5.00)]* 
f: 
2.16 (1.80-2.59) 
(93.2%, <0.001) 
 
Higher socioeconomic 
status 
[21: 1.45 (0.96-2.20)]*ϯ, 48: 2.79 (2.51-3.10), 
[67: 1.8 (NR),                  82: 1.67 (1.00-3.33)]* 
1.97 (1.20-3.24), 
(82.3%, 0.004) 
Higher level of partner’s 
education 
[49: 1.10 (1.00-1.20)]*ϯ  
Employed (currently) 70: 2.37 (1.16-4.85)  
Medicaid coverage or 
private insurance 
38: 2.17 (1.15-4.17),      40: 3.57 (1.16-11.11),    
[51: 1.33 (1.18-1.52),     74: 1.61 (1.29-2.01),      
47: 1.60 (1.10-2.30)]* 
1.54 (1.29-1.85), 
(41.5%, 0.145) 
Relationship and social 
activities 
  
Living with 
partner/married 
[43: 2.45 (1.17-5.09)]ϯ,  [51: 1.32 (1.17-1.48), 
54: 1.84 (1.20-2.80),       64: 1.42 (1.34-1.51)], 
65: 2.63 (1.41-4.76),      69: 1.52 (1.47-1.57), 
77: 1.75 (1.30-2.35)]* 
1.49 (1.38-1.61), 
(60.5%, 0.019) 
House wife [77: 0.70 (0.51-0.96)]*  
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Support from partner and 
others 
[46: #]*  
Partner or household 
member smokes 
[21:0.5 (0.44-0.57)]*ϯ,  38: 0.49 (0.26-0.93), 
44: (NR),                       59: 0.20 (0.12-0.32),    
70: 0.35 (0.17-0.70),     71: 0.20 (0.10-0.20), 
[46: 0.37 (0.20-0.69),    62: 0.56 (0.36-0.87), 
72: 0.40 (0.30-0.50),     73: 0.57 (0.38-0.87),  
76: 0.44 (0.37-0.52),     78: 0.55 (0.37-0.83),   
79: 0.46 (0.30-0.70),     82: 0.60 (0.50-0.80)]*, 
[75: 0.17 (0.03-0.68)]ϯ 
0.42 (0.35-0.50), 
(71.9%, <0.001) 
Exposure to second-hand 
/environmental/passive 
smoking 
[42: 0.66 (0.42-1.03)]*ϯ, [63: 0.70 (0.60-0.81), 
32: (NR)]*,                       44: (NR),                    
71: 0.20 (0.10-0.20) 
0.45 (0.20-1.02), 
(95.3%, <0.001) 
Poorer childhood 
circumstances 
[60: 0.70 (0.54-0.91)]*  
Poorer current 
circumstances 
[60: 0.35 (0.23-0.54)]*  
Smoking and related 
factors  
  
Higher Fagerstrom test of 
Higher cigarette 
dependence 
[39: 0.60 (0.45-0.81)]*ϯ  
Higher Heaviness of 
Smoking Index 
[36: 0.59 (0.47-0.74),    39: 0.65 (0.48-0.87)]*ϯ, 
59: 0.21 (0.13-0.35) 
0.45 (0.27-0.77), 
(87.5%,<0.001)  
Higher Non-Heaviness of 
Smoking Index 
[39: 0.65 (0.48-0.88)]*ϯ   
Higher pre-pregnancy 
cigarette consumption 
[34: 0.50 (0.40-0.60),    36: (NR),                      
37: 0.85 (0.83-0.87),     39: (NR)]*ϯ,                  
[43: 0.37 (0.30-0.47)]ϯ, 40: 0.15 (0.06-0.32),   
44: (NR),                       48: (NR),                       
55: 0.83 (0.77-0.91),     56: 0.38 (0.16-0.88),     
58: 0.36 (0.18-0.69),     66: 0.13 (0.05-0.37),     
68: 0.08 (0.04-0.16),    [32: (NR),                        
45: 0.02 (0.01-0.04),     47: 0.23 (0.16-0.34), 
51: 0.27 (0.24-0.30),     54: 0.40 (0.29-0.59),      
61: 0.36 (0.19-0.68),     62: 0.21 (0.13-0.35), 
63: 0.41 (0.33- 0.51),    65: 0.45 (0.31-0.64),                   
69: 0.35 (0.34-0.36),     72: 0.30 (0.20-0.30), 
73: 0.12 (0.05-0.31),     76: 0.57 (0.52-0.63),    
80: 0.43 (0.24-0.74),     82: 0.30 (0.30-0.40)]* 
d:  
0.28 (0.22-0.35), 
(96.5%, <0.001) 
e:  
0.57 (0.38-0.85), 
(98.2%, <0.001) 
Higher baseline cotinine 
level 
[31: 0.92 (0.88-0.95)]*, [41: 0.96 (0.92-0.99), 
42: 0.09 (0.05-0.17)]*ϯ                   
0.78 (0.64-0.94), 
(96.6%, <0.001) 
Higher baseline carbon 
monoxide level 
[39: 0.55 (0.37-0.80)]*ϯ  
Higher Urges/craving to 
smoke 
[39: 0.69 (0.51-0.93)]*ϯ,  59: 0.27 (0.15-0.49)  
Higher sensation of 
withdrawal 
59: 0.27 (0.17-0.44)  
Shorter duration (years) of 
smoking 
[42: 2.79 (1.61-4.82)]*ϯ,  48: (NR)  
Pre-pregnancy, lower time 
to first cigarette on waking  
[37:0.51 (0.34-0.76),   36: 0.26 (0.11-0.65)]*ϯ, 
38: 0.28 (0.15-0.55) 
0.37 (0.23-0.59), 
(42.2%, 0.177) 
    Page 29 of 31 
 
Smoking status in the first 
two weeks following the 
quit attempt. 
[35: 30.4 (6.0-154.6)]ϯ  
Pre-pregnancy/prior 
attempt to quit 
[34: 2.30 (1.10-4.50),  36: 3.55 (1.65-7.63)]*ϯ  
Attempts to quit during 
pregnancy 
[36: 1.18 (1.00-1.38)]*ϯ  
Interaction of age and 
number of years smoked 
[81: 2.83 (1.44-5.58)]*ϯ  
Age at onset of smoking [43: 1.15 (1.04-1.28)]ϯ, [78: 1.16 (1.08-1.25)]*  
Daily  use of pre-
pregnancy marijuana 
[61: 0.54 (0.31-0.87)]*  
No alcohol use before 
and/or during pregnancy 
[47: 2.10 (1.00-4.10),    58: 2.58 (1.00-6.66),   
82: 2.00 (1.11-3.33)]*, [49: 1.86 (1.07-3.24)]*ϯ 
2.03 (1.47-2.80), 
(0.0%, 0.950) 
 
Interaction of delayed 
discounting of spontaneous 
quit  and smoking rate 
[43: 0.74 (0.61-0.90)]ϯ  
Coffee consumption during 
pregnancy 
[72: 0.20 (0.20-0.30)]*  
Pregnancy related factors   
Primiparity [33:(NR),                       75: 3.92 (1.78-8.99)]ϯ, 
44: (NR),                       48: 2.19 (NR),             
52: 1.48 (1.09-2.01),     70: 5.05 (1.90-13.27), 
71: 1.67 (1.11-2.00),    [49: 2.00 (1.15-3.45)]*ϯ, 
[45: 2.04 (1.16-3.57),    47: 1.90 (1.40-2.50), 
51: 1.88 (1.69-2.10),     60: 2.29 (1.92-2.72), 
61: 2.78 (1.54-5.00),     63: 2.17 (1.85-2.50), 
65: 1.64 (1.04-2.57),     67: 1.68 (1.62-1.73),   
73: 1.49 (1.03-2.17),     74: 2.22 (2.04-2.44), 
77: 1.24 (1.03-1.49),     78: 1.59 (1.06-2.38), 
79: 1.54 (1.17-2.03),     82: 1.67 (1.25-2.00)]* 
g:  
1.85 (1.68-2.05), 
(78.4%, <0.001) 
 
Women who were 
perceived to have adequate 
prenatal care 
48: (NR),                     [67: 2.33 (1.91-2.85), 
69: 1.67 (1.56-1.75),    73: 2.72 (1.3-5.68),    
74: 1.27 (1.18-1.37),    80: 1.72 (1.02-2.91)]* 
1.74 (1.38-2.19), 
(92.3%, <0.001) 
Planned breastfeeding 58: 3.70 (1.60-8.80),   [50: 1.73 (1.01-2.98),    
69: 1.99 (1.94-2.05),    82: 2.00 (1.67-2.50)]* 
1.99 (1.94-2.05), 
(0.0%, 0.514) 
Prior preterm birth [69: 0.82 (0.76-0.88)]*  
Planned  pregnancy [77: 1.31 (1.00-1.72),   79: (NR)]*   
Health Related factors   
Severe nausea 44: (NR),                    70: 2.59 (1.11-6.04)  
Community services card 
holders 
70: 0.41 (0.19-0.86)  
Known higher risk of   
foetal harm 
59: 3.67 (1.73-7.78)  
Short sleep duration [63: 0.62 (0.51-0.75)]*  
Use of folic acid [77: 1.59 (1.22-2.06)]*  
Psychological factors    
No depression  [30: 6.28 (0.76-52.17)]ϯ,  
[31: 2.69 (1.27-5.68)]*,   40: 2.39 (1.22-4.70),    
52: 1.09 (1.01-1.17) 
h:  
2.65 (1.62-4.30), 
(0.0%, 0.694) 
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Per unit increase in anxiety 
score 
[57: 0.99 (0.98-1.00)]*  
Stress during pregnancy [34:0.80 (0.70-0.90)]*ϯ, [43: 0.86 (0.76-0.97)]ϯ,  
[57: 0.57 (0.35-0.94),     61: 0.64 (0.38-1.06)]*, 
59: 0.54 (0.34-0.85), 
i:  
0.58 (0.44-0.77), 
(0.0%, 0.887) 
Perception of harm to baby 
due to smoking 
[43: 14.42 (1.77-117.25)]ϯ,    
Higher self-
efficacy/confidence for 
quitting 
[42: 3.59 (2.29-5.65),   37: 0.84 (0.76-0.93)]*ϯ, 
[32:(NR)]*                    53: (NR),        
 
Higher readiness for 
quitting 
[52: 1.05 (1.02-1.08)]  
Domestic violence,   [57: 0.31 (0.12-0.84)]*  
a: Effect estimates extracted are odds ratios (OR: adjusted majority), relative risk ratios (RR: one study 
[69]) or prevalence ratio (PR: one study [21]). If an effect estimate was not reported, an unadjusted OR 
and 95% confidence interval (95% CI) was estimated from the available data. 
b: The effect estimate (e.g., OR) shows the direction of association; a factor is said to be associated with an 
increase likelihood of smoking cessation if OR>1 and decrease likelihood if OR<1. To ensure consistency 
of the effect estimates for meta-analysis, for some of the studies, the effect estimates are transformed to 
represent smoking cessation outcome and/or (appropriate category versus reference) of the predictor.  
c: Using DerSimonian and Laird random effects model for meta-analysis, the effect estimates were 
combined to compute a pooled OR for the association. 
p: Represents the p-values for testing the hypothesis that the studies are homogeneous.  
d: The predictor (factor) is assessed as a categorical variable. 
e: The predictor is assessed as a continuous variable. 
f: Excluded [40] from meta-analysis as it reported OR (95% CI) for continuous age (years) of education. 
g: Excluded [52] from meta-analysis as it reported OR (95% CI) for continuous number of children. 
h: Excluded [52] from meta-analysis as it reported OR (95% CI) for continuous score of the depression 
scale. 
i: Excluded two studies [34 and 43], as they reported OR (95% CI) for continuous score of the stress scale.  
*: Studies methodology is classed as of high quality by the NOQAS (i.e., score of 7 and above). 
ϯ: Study(ies) with all or most of the participants made a quit attempt. 
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*ϯ: Studies enclosed are fulfilling both of the above two criteria (* and ϯ. 
#: The OR (95% CI) interpretation is wrong in the original study, therefore it was not reported. 
(NR): Effect estimate and/or 95% CI are not reported and can not be estimated from the available results 
published in the study. 
I2: I-square is the measure (index) of heterogeneity among the studies included in the meta-analysis. More 
than 75% can be considered as high heterogeneity, more than 50% moderate, and 25% as low 
heterogeneity [96]. 
p: Represents the p-values for testing the hypothesis that the studies are homogeneous. 
 
